Our caring approach has made us a leader in many of our therapeutic areas, but we want to achieve more. Looking forward, we need to develop even more groundbreaking, new ways to transform more patients’ lives, adding value to society, while delivering value to our stakeholders. This purpose keeps patients and their needs at the center of everything we do.
In practice this means we focus on developing treatments for conditions where the impact of our drugs can make an immediate and tangible difference for patients. This might be a therapy to treat an extremely rare and life-threatening disease like Angioedema, Hunter Syndrome or Fabry Disease; or a medicine for a specialist condition like ADHD or ulcerative colitis; or a treatment to help the healing of diabetic foot ulcers which if not treated effectively, can dramatically affect the lives of the patient and their whole family.